![Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting - Vieira Barbosa - 2021 - Hepatology Communications - Wiley Online Library Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting - Vieira Barbosa - 2021 - Hepatology Communications - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/2457052f-03a6-47b9-8df4-a096ef339977/hep41618-fig-0002-m.jpg)
Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting - Vieira Barbosa - 2021 - Hepatology Communications - Wiley Online Library
![Liverfy on Twitter: "I finally found some time to work on liverfy 😑 Inspired by this tweet, I'm testing to code a #FIB4 calculator https://t.co/ylkFbS8UXZ" / Twitter Liverfy on Twitter: "I finally found some time to work on liverfy 😑 Inspired by this tweet, I'm testing to code a #FIB4 calculator https://t.co/ylkFbS8UXZ" / Twitter](https://pbs.twimg.com/media/FK6ny76VUAAtgK9.jpg)
Liverfy on Twitter: "I finally found some time to work on liverfy 😑 Inspired by this tweet, I'm testing to code a #FIB4 calculator https://t.co/ylkFbS8UXZ" / Twitter
![Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts | Actas Dermo-Sifiliográficas Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//00017310/0000011400000005/v2_202306061222/S0001731023002922/v2_202306061222/en/main.assets/gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6AswyQEetMYgBmF155XNCwTXc/Mu7S3KgtJO5254HnXuoJZIdB8Aa31aNeaF7WECjTCPq8afcxm/gxDvYGTD6L82tKr+tLv+JJZ1ahkre5f4PVrwz0H9ywguHiG022pDY8jvf0nsLFu7HCkhzbpBQPqgRGun6UmYe31PLjmvGhXsMHFi7tY4EDKDpjd9X8FnG3NtxVn1mCME0aoxYz8+vf+GCqor/Md0U3GbsI58KszN3)
Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts | Actas Dermo-Sifiliográficas
![PDF) FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic PDF) FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic](https://www.researchgate.net/publication/349305919/figure/tbl2/AS:991284500103173@1613352050493/Summary-sensitivities-specificities-PPV-and-NPV-of-APRI-FIB-4-BARD-score-and-NAFLD_Q320.jpg)
PDF) FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
![The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0929664621003442-gr2.jpg)
The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect
![Core Concepts - Evaluation and Staging of Liver Fibrosis - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online Core Concepts - Evaluation and Staging of Liver Fibrosis - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online](https://cdn.hepatitisc.uw.edu/doc/320-1/optimal-cutoffs-sensitivity-specificity-positive-predictive-value-negative-predictive-value.jpg)
Core Concepts - Evaluation and Staging of Liver Fibrosis - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online
Hepatitis B Foundation - Please discuss using the FIB-4 calculation with your doctor. You can find the calculator online, where you can plug in your ALT, AST, age and platelet count. There
![Scott Isaacs on Twitter: "Identify patients at high-risk for #NAFLD and use the FIB-4 index for fibrosis risk stratification. For indeterminate risk, use elastography or serum biomarkers as a second #NIT. @TheAACE @ Scott Isaacs on Twitter: "Identify patients at high-risk for #NAFLD and use the FIB-4 index for fibrosis risk stratification. For indeterminate risk, use elastography or serum biomarkers as a second #NIT. @TheAACE @](https://pbs.twimg.com/media/FTddTdTXEAE__xR.jpg)
Scott Isaacs on Twitter: "Identify patients at high-risk for #NAFLD and use the FIB-4 index for fibrosis risk stratification. For indeterminate risk, use elastography or serum biomarkers as a second #NIT. @TheAACE @
![Abstract 17098: Liver Fibrosis and Associated Cardiovascular Disease Risk and Its Predictors Among US Adults With and Without Diabetes | Circulation Abstract 17098: Liver Fibrosis and Associated Cardiovascular Disease Risk and Its Predictors Among US Adults With and Without Diabetes | Circulation](https://www.ahajournals.org/cms/asset/13813e1a-fac4-4055-9c5f-7b31d2afd7ee/g17098.jpg)